Home » DSM partner with Panaceutics to bring personalized nutrition to consumers
Health Industry News Top Slider

DSM partner with Panaceutics to bring personalized nutrition to consumers

DSM

Partner to bring affordable personalized nutrition products to the market, providing consumers with access to the specific nutrients they need for optimal health.

The Personalized Nutrition and Wellness segment is expected to see continued growth, as people become better informed on the importance of maintaining health and wellbeing. Delivering the right combination of nutritional ingredients at effective and safe doses, Panaceutics Nutrition will allow individuals to easily optimize their health in a way that suits their unique needs.

Personalized nutrition

In line with the latest consumer preferences, nutritional solutions are delivered in convenient organic food purees or gel suspensions, therefore removing the need for individuals to take multiple supplements. DSM is a minority investor in Panaceutics through its venture investment arm, DSM Venturing, and the companies will collaborate on several personalized health projects, including adapting Panaceutics’ exclusive technology to manufacture additional formats, such as personalized beverages and bars. Although the partnership with DSM focuses on personalized nutrition, the Panaceutics technology is also a significant tool in personalized medicine therapies, where it is already helping to prevent and manage medical conditions.

Peter De-Meester, VP Global Strategy and Personalized Nutrition, DSM, states: “As consumers become increasingly health-conscious, we believe personalized nutrition will continue to disrupt the nutrition and supplement market and grow into a multi-billion-dollar industry. Realizing this potential and to remain at the forefront of innovation in this field, we continue to expand and establish new partners in the space. This includes innovative early stage companies like Panaceutics, which is making personalized nutrition solutions available to populations across the world.”

Edison Hudson, CEO and Co-Founder, Panaceutics, stated: “Our disruptive technology uses proprietary robotic technology, in combination with digital health platforms, to rapidly manufacture products to serve individuals needs and health conditions. This exciting venture with DSM will help us to reach our goal of serving large numbers of people with data-driven personalization.”